A hot year for biotech IPOs cools off as investors worry about risk, declines in stock prices

  • by: JOSHUA FREED , Associated Press
  • Updated: December 3, 2013 - 5:20 PM

Biotech IPOs have gone from hot to cold.

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT